Sign inJoin waitlistJoin the waitlist

Bei Jiang

Assistant Professor (Clinical), Department of Medical Oncology, Department of Medical Oncology · West Virginia University School of Medicine

Credentials: · · · · · ·

History

West Virginia University School of Medicine
Present

Hematology and Medical Oncology
West Virginia University School of Medicine
2021–2024
NYC Health + Hospitals Lincoln Hospital
2018–2021
Tongji Medical College
2007–2011

Research

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma
Blood · 2015 · 195 citations
Quantitative analysis of antiradical phenolic constituents from fourteen edible Myrtaceae fruits
Food Chemistry · 2008 · 102 citations
Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid…
Journal of Agricultural and Food Chemistry · 2006 · First of 5 authors · 72 citations

IW
I. Weinstein
5 papers
CH
Caroline Hwang
1 paper
CC
Chung-Che Chang
1 paper
Dennis Weisenburger
1 paper
Joseph Rohr
1 paper
Julie Vose
1 paper
KF
Kai Fu
1 paper
Konstantinos Sdrimas
1 paper
Laurel Lyckholm
1 paper
Madhukar Trivedi
1 paper
Maria Oquendo
1 paper
Maurizio Fava
1 paper

Clinical trials

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Site PI · Recruiting
Natera, Inc.
2026–2037
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Site PI · Recruiting · Phase 1
NiKang Therapeutics, Inc.
2025–2027
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032